The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Trend Is Expected For The Porcine Vaccine Market From 2026 To 2030?
The porcine vaccine market size has shown robust expansion in recent years. It is anticipated to expand from $2.05 billion in 2025 to $2.25 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. The factors contributing to this historic growth include outbreaks of swine diseases, increased pork consumption, the development of traditional vaccines, a rise in veterinary awareness, and the expansion of hog farming infrastructure.
The porcine vaccine market is projected to experience substantial expansion over the upcoming years. By 2030, its value is anticipated to reach $3.22 billion, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period is driven by several factors, including the increasing development of recombinant and DNA vaccines, the embrace of precision veterinary medicine, a heightened emphasis on herd immunity initiatives, progress in vaccine delivery technologies, and growing governmental efforts to improve livestock health. Key trends expected during this period involve the widespread use of multi-strain vaccines for pigs, a stronger emphasis on preventing diseases in swine populations, increased funding for swine immunization schemes, the incorporation of veterinary advisory services into farm operations, and the expansion of cold chain networks for vaccine distribution.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp
Which Strategic Drivers Are Supporting The Porcine Vaccine Market Development?
The increasing pork consumption is expected to propel the growth of the porcine vaccine market going forward. Pork consumption is the quantity of pork meat that people or groups eat in a specific amount of time. The consumption of pork has increased in tandem with the growing global population and the growing demand for protein. The porcine vaccine market supports increasing pork consumption, as vaccines help prevent diseases in pigs, improve herd health, and ensure a stable supply of safe and high-quality pork products. For instance, in July 2024, according to the INAPORC (Interprofession Nationale Porcine), a France-based national pork association, in 2023, pork was still the most consumed meat in France, with about 30.6 kg per person per year. Therefore, increasing pork consumption is driving the growth of the porcine vaccine market.
How Is The Porcine Vaccine Market Structured Across Different Market Segments?
The porcine vaccine market covered in this report is segmented –
1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines
2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications
3) By End User: Veterinary Hospitals, Hog Or Pig Production Farm
Subsegments:
1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines
2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines
3) By Toxoid Vaccines: Inactivated Toxins
4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines
5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines
6) By DNA Vaccines: Plasmid DNA Vaccines
What Trends Are Driving Changes In The Porcine Vaccine Market?
Major companies operating in the porcine vaccine market are adapting strategic partnerships to enhance their research and development capabilities and strengthen their competitive position in the rapidly evolving animal health industry. The collaboration makes use of TVG’s experience in vaccine technology and Pirbright’s expertise in African swine fever (ASF) research. The goal of this partnership is to improve the vaccine development process and develop novel approaches that have the potential to greatly improve swine health. For instance, in May 2024, The Pirbright Institute, a UK-based research institute, partnered with The Vaccine Group (TVG), a UK-based company, to develop a vaccine for African swine fever (ASF), The research aims to develop vaccines to prevent African swine fever (ASF) by using bovine herpesvirus 4 (BoHV-4) as a foundation. This method takes advantage of the latest breakthroughs in ASF vaccine research and pig immunology to design more efficient vaccines. The initiative is funded by the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).
Which Companies Are Engaged In The Porcine Vaccine Market Environment?
North America is the largest region in the porcine vaccine market in 2025. The regions covered in the porcine vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access The Complete Porcine Vaccine Market Report:
https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report
Which Region Stands As The Largest Contributor To The Porcine Vaccine Market?
North America is the largest region in the porcine vaccine market in 2025. The regions covered in the porcine vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Porcine Vaccine Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model